BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11533075)

  • 1. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
    Leonard N; Chaggar R; Jones C; Takahashi M; Nikitopoulou A; Lakhani SR
    J Clin Pathol; 2001 Sep; 54(9):689-92. PubMed ID: 11533075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas.
    Biggs PJ; Chapman P; Lakhani SR; Burn J; Stratton MR
    Oncogene; 1996 Mar; 12(6):1375-7. PubMed ID: 8649842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
    Rajan N; Elliott R; Clewes O; Mackay A; Reis-Filho JS; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
    Oncogene; 2011 Oct; 30(41):4243-60. PubMed ID: 21552290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma?
    Choi HR; Batsakis JG; Callender DL; Prieto VG; Luna MA; El-Naggar AK
    Am J Surg Pathol; 2002 Jun; 26(6):778-83. PubMed ID: 12023583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.
    Jenner MW; Leone PE; Walker BA; Ross FM; Johnson DC; Gonzalez D; Chiecchio L; Dachs Cabanas E; Dagrada GP; Nightingale M; Protheroe RK; Stockley D; Else M; Dickens NJ; Cross NC; Davies FE; Morgan GJ
    Blood; 2007 Nov; 110(9):3291-300. PubMed ID: 17609426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous appendage tumors: familial cylindromatosis and associated tumors update.
    Lian F; Cockerell CJ
    Adv Dermatol; 2005; 21():217-34. PubMed ID: 16350444
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the familial cylindromatosis tumour-suppressor gene.
    Bignell GR; Warren W; Seal S; Takahashi M; Rapley E; Barfoot R; Green H; Brown C; Biggs PJ; Lakhani SR; Jones C; Hansen J; Blair E; Hofmann B; Siebert R; Turner G; Evans DG; Schrander-Stumpel C; Beemer FA; van Den Ouweland A; Halley D; Delpech B; Cleveland MG; Leigh I; Leisti J; Rasmussen S
    Nat Genet; 2000 Jun; 25(2):160-5. PubMed ID: 10835629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new hereditary cylindromatosis family associated with CYLD1 on chromosome 16.
    Thomson SA; Rasmussen SA; Zhang J; Wallace MR
    Hum Genet; 1999; 105(1-2):171-3. PubMed ID: 10480375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13.
    Takahashi M; Rapley E; Biggs PJ; Lakhani SR; Cooke D; Hansen J; Blair E; Hofmann B; Siebert R; Turner G; Evans DG; Schrander-Stumpel C; Beemer FA; van Vloten WA; Breuning MH; van den Ouweland A; Halley D; Delpech B; Cleveland M; Leigh I; Chapman P; Burn J; Hohl D; Görög JP; Seal S; Mangion J
    Hum Genet; 2000 Jan; 106(1):58-65. PubMed ID: 10982183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.
    Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
    J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathologic and molecular biologic study of patients presenting with few adnexal tumors (two to four) from the morphological spectrum of Brooke-Spiegler syndrome.
    Kacerovska D; Vanecek T; Spagnolo DV; Bisceglia M; Zelger B; Michal M; Kazakov DV
    Am J Dermatopathol; 2013 Feb; 35(1):19-24. PubMed ID: 22588548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
    Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
    Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene.
    Biggs PJ; Wooster R; Ford D; Chapman P; Mangion J; Quirk Y; Easton DF; Burn J; Stratton MR
    Nat Genet; 1995 Dec; 11(4):441-3. PubMed ID: 7493027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Br J Cancer; 1998 Nov; 78(9):1181-7. PubMed ID: 9820177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
    Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
    J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome.
    Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT
    Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors.
    Kazakov DV; Schaller J; Vanecek T; Kacerovska D; Michal M
    J Cutan Pathol; 2010 Aug; 37(8):886-90. PubMed ID: 20132422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.